Sequential high-dose therapy plus rituximab as in vivo purging agent in low grade lymphomas

被引：0
|
作者：
Mazza, P
Prudenzano, A
Pricolo, G
Stani, L
Maggi, A
Amurri, B
Palazzo, G
Pisapia, G
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] High molecular remission rate in high risk follicular lymphoma with sequential high-dose therapy and rituximab as purging in vivo
    Specchia, M. R.
    Pricolo, G.
    Casulli, F.
    Mazza, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 189 - 189
  • [2] In vivo purging of circulating CD34+ progenitor cells in low-grade lymphoma with rituximab and high-dose chemotherapy.
    Gianni, AM
    Magni, M
    Di Nicola, M
    Gandola, L
    Lombardi, F
    Dastoli, G
    Matteucci, P
    Devizzi, L
    Bregni, M
    Campana, S
    Corradini, P
    Pileri, A
    Tarella, C
    BLOOD, 1998, 92 (10) : 119A - 119A
  • [3] A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
    Arcaini, L
    Orlandi, E
    Alessandrino, EP
    Iacona, I
    Brusamolino, E
    Bonfichi, M
    Bernasconi, P
    Calatroni, S
    Tenore, A
    Montanari, F
    Troletti, D
    Pascutto, C
    Regazzi, M
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (02) : 175 - 179
  • [4] A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
    L Arcaini
    E Orlandi
    E P Alessandrino
    I Iacona
    E Brusamolino
    M Bonfichi
    P Bernasconi
    S Calatroni
    A Tenore
    F Montanari
    D Troletti
    C Pascutto
    M Regazzi
    M Lazzarino
    Bone Marrow Transplantation, 2004, 34 : 175 - 179
  • [5] Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as hi vivo purging and to maintain re ion following high-dose therapy
    Pettengell, R.
    Schmitz, N.
    Gisselbrecht, C.
    Caballero, D.
    Colombat, P.
    Conde, E.
    Metzner, B.
    Walewski, J. A.
    Geisler, C.
    Goldstone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BONE MARROW TRANSPLANTATION, 2005, 35 : S385 - S385
  • [7] High-dose therapy and transplantation for low-grade lymphoma
    Horning, SJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (05) : 919 - &
  • [8] Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia
    Coronado-Alejandro, Edgar Ulises
    Martinez-Hernandez, Juan Pablo
    Gomez-De Leon, Andres
    Colunga-Pedraza, Perla Rocio
    Jaime-Perez, Jose Carlos
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 778 - 779
  • [9] Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell lymphomas. A single center study
    Belhadj, K
    Delfau-Larue, MH
    Elgnaoui, T
    Beaujean, F
    Beaumont, JL
    Pautas, C
    Gaillard, I
    Kirova, Y
    Allain, A
    Gaulard, P
    Farcet, JP
    Reyes, F
    Haioun, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S89 - S89
  • [10] High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz
    Moreno-Jaime, Brizio
    Carlos Jaime-Perez, Jose
    Alejandro Ceballos-Lopez, Adrian
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Graciela Cantu-Rodriguez, Olga
    Homero Gutierrez-Aguirre, Cesar
    Sanchez-Cardenas, Monica
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (06) : 494 - 500
12345